Mavorixafor + Cyp2d6 Substrates Highly Dependent On Cyp2d6 For Clearance Interaction
Contraindicatedinteraction on record
Description
Concomitant use is contraindicated. Mavorixafor inhibits CYP2D6, increasing substrate exposure and risk of adverse reactions.
Mechanism
Inhibition of CYP2D6-mediated metabolism of substrates
Source: NLP:mavorixafor